Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,838 | -31,934 | -101,944 | -71,450 | -48,063 |
| Depreciation Amortization | 794 | 377 | 1,168 | 720 | 395 |
| Accounts receivable | -657 | -234 | -14 | -26 | -20 |
| Accounts payable and accrued liabilities | 2,995 | -2,770 | 76 | -4,637 | -5,447 |
| Other Working Capital | -916 | -3,471 | 402 | -4,804 | -5,779 |
| Other Operating Activity | 4,892 | 6,419 | 11,461 | 12,915 | 11,071 |
| Operating Cash Flow | $-69,730 | $-31,613 | $-88,851 | $-67,282 | $-47,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -62,128 | 12,341 | -69,752 | -95,172 | -17,980 |
| PPE Investments | -387 | -248 | -1,326 | -80 | -76 |
| Investing Cash Flow | $-62,515 | $12,093 | $-71,078 | $-95,252 | $-18,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,961 | N/A | 48,868 | 23,899 | 24,148 |
| Common Stock Issued | 139,034 | N/A | 94,205 | 94,268 | N/A |
| Common Stock Repurchased | -824 | -824 | -864 | -864 | -864 |
| Financing Cash Flow | $188,171 | $-824 | $142,209 | $117,303 | $23,284 |
| Beginning Cash Position | 46,345 | 46,345 | 64,065 | 64,065 | 64,065 |
| End Cash Position | 102,271 | 26,001 | 46,345 | 18,834 | 21,450 |
| Net Cash Flow | $55,926 | $-20,344 | $-17,720 | $-45,231 | $-42,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,730 | -31,613 | -88,851 | -67,282 | -47,843 |
| Capital Expenditure | -387 | -248 | -1,326 | -80 | -76 |
| Free Cash Flow | -70,117 | -31,861 | -90,177 | -67,362 | -47,919 |